Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens.
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
08 Feb 2024
08 Feb 2024
Historique:
received:
04
01
2024
pmc-release:
08
02
2025
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
epublish
Résumé
This Patent Highlight explores the emerging role of 5-HT2A receptor modulators and psychoplastogens in neuropsychiatric treatment. It delves into these novel compounds' molecular mechanisms, therapeutic potential, and challenges, highlighting their therapeutic potential in mental health care.
Identifiants
pubmed: 38352827
doi: 10.1021/acsmedchemlett.4c00003
pmc: PMC10860177
doi:
Types de publication
Editorial
Langues
eng
Pagination
171-173Informations de copyright
Published 2024 by American Chemical Society.
Déclaration de conflit d'intérêts
The author declares no competing financial interest.